These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9086437

  • 1. Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update.
    Thiele J, Kvasnicka HM, Fischer R, Diehl V.
    Leuk Lymphoma; 1997 Feb; 24(5-6):463-81. PubMed ID: 9086437
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow CD34+ progenitor cells in Philadelphia chromosome-negative chronic myeloproliferative disorders--a clinicopathological study on 575 patients.
    Thiele J, Kvasnicka HM, Diehl V.
    Leuk Lymphoma; 2005 May; 46(5):709-15. PubMed ID: 16019508
    [Abstract] [Full Text] [Related]

  • 3. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V.
    Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
    [Abstract] [Full Text] [Related]

  • 4. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Flucke U, Spoer C, Paperno S, Leder LD, Schaefer UW.
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [Abstract] [Full Text] [Related]

  • 5. CD34+ stem cells in chronic myeloproliferative disorders.
    Thiele J, Kvasnicka HM.
    Histol Histopathol; 2002 Apr; 17(2):507-21. PubMed ID: 11962756
    [Abstract] [Full Text] [Related]

  • 6. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Niederle N, Zirbes TK, Schmidt M, Dammasch J, Meuter BR, Leder LD, Kloke O, Diehl V.
    Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders.
    Kvasnicka HM, Thiele J.
    Histol Histopathol; 2004 Oct; 19(4):1245-60. PubMed ID: 15375769
    [Abstract] [Full Text] [Related]

  • 8. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
    Martyré MC.
    Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
    [Abstract] [Full Text] [Related]

  • 9. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J, Kvasnicka HM.
    Pathobiology; 2007 Dec; 74(2):89-96. PubMed ID: 17587880
    [Abstract] [Full Text] [Related]

  • 10. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
    Thiele J, Hoeppner B, Zankovich R, Fischer R.
    Virchows Arch A Pathol Anat Histopathol; 1989 Dec; 415(3):191-202. PubMed ID: 2503923
    [Abstract] [Full Text] [Related]

  • 11. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T, Georgii A, Choritz H.
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [Abstract] [Full Text] [Related]

  • 12. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia.
    Méhes G, Tzankov A, Hebeda K, Anagnostopoulos I, Krenács L, Bedekovics J.
    Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163
    [Abstract] [Full Text] [Related]

  • 13. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM.
    Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
    [Abstract] [Full Text] [Related]

  • 14. Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.
    Thiele J, Kvasnicka HM.
    Histol Histopathol; 2006 Dec; 21(12):1367-78. PubMed ID: 16977587
    [Abstract] [Full Text] [Related]

  • 15. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.
    Thiele J, Kvasnicka HM, Werden C, Zankovich R, Diehl V, Fischer R.
    Leuk Lymphoma; 1996 Jul; 22(3-4):303-17. PubMed ID: 8819080
    [Abstract] [Full Text] [Related]

  • 16. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
    [Abstract] [Full Text] [Related]

  • 17. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
    Dolgikh TY, Senchukova SR, Vinogradova EV, Krinitsyna YM.
    Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
    [Abstract] [Full Text] [Related]

  • 18. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL, Ortiz-Hidalgo C.
    Gac Med Mex; 2016 Apr; 152(3):407-18. PubMed ID: 27335198
    [Abstract] [Full Text] [Related]

  • 19. Myelofibrosis in the myeloproliferative disorders.
    Ellis JT, Peterson P.
    Prog Clin Biol Res; 1984 Apr; 154():19-42. PubMed ID: 6382293
    [Abstract] [Full Text] [Related]

  • 20. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
    Wilkins BS.
    Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.